Companies and Markets
Market Research A to Z | Company Profiles A to Z | Register | Contact Us
+44 (0) 203 086 8600 Call us on

Excipients in Pharmaceuticals

3588.64

Select License Type

Electronic License

Electronic License

An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.

Site License

Site License

An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.

Corporate License

Corporate License

An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£3,588.64

Change Currency

GBP EURO USD

Market

Healthcare and Medical

Report Type

Market Research

Country

Global

Published

4 August 2011

Number of Pages

275

Report Delivery

Email

Delivery Lead Time

1-3 hours, 24 hour max

Publisher

BCC Research

File Format

PDF

- The global excipients market was at $4.6 billion in 2010 and it is expected to reach at $4.9 billion in 2011. It is further anticipated to increase to $6.7 billion by 2016 at a compound annual growth rate (CAGR) of 6.5%.

- The market for organic chemicals was at $4.3 billion approximately in 2010 and it is expected to reach at $4.5 billion in 2011. It is further anticipated to increase to $6.3 billion by 2016 at a compound annual growth rate (CAGR) of 6.6%.

- The market for inorganic chemicals was at $248 million approximately in 2010 and it is expected to reach at $268 millions in 2011. It is further anticipated to increase to $350 million by 2016 at a compound annual growth rate (CAGR) of 5.5%.

Among the significant forces that continue to affect the global excipients industry in 2011 are a crisis in the global supply chain, the demands of Quality by Design (QbD), and worries about drug safety. Positive trends include the development of creative ideas in response to the need for new excipients and new levels of cooperation between major players (e.g., Dow and Colorcon). These forces are reshaping the global market for excipients.

GOALS AND OBJECTIVES

The primary goals of this technical/market report are to provide a detailed analysis of the current excipients market and a forecast of what the market will look like in 5 years. The specific objectives are (1) identify excipients being used; (2) quantify global market volume; (3) track important developments; (4) analyze the structure of the industry and its driving forces; (5) examine the most active companies and describe how they respond to market demands; and (6) provide data with which the reader can further evaluate the industry.

AUDIENCE

As a market and technology summary, this report consolidates a wide range of industrial and technical information that should aid excipient suppliers, chemical companies, drug manufacturers, healthcare regulators, and congressional staffers to stay current with today's market. The report should be of value to companies interested in entering or expanding their involvement in the field. The report should provide senior marketing personnel and executive planners with insight about what materials can best satisfy customer demands. Market projections may be of interest to venture capitalists interested in exploring commercialization opportunities, as well as companies and personnel involved in designing and constructing chemical and excipient manufacturing plants and/or those who service such plants. The report offers useful background to consultants in the field. The report can serve as an introductory resource for newcomers to the business, including new employees. In addition, the report can offer background to governmental officials examining reform.

SCOPE OF REPORT

Excipients in Pharmaceuticals offers coverage of the most important issues surrounding excipients: technological, regulatory, economic, and political issues, and so on.

Excluded from the study are ingredients for cosmetics, personal care, food, quasi-medical, unorthodox, alternative, home remedies, underground and/or illegal drugs, and veterinary drugs.

This report organizes information from diverse sources into sections entitled Summary, Overview, Technology, Industry Structure, and Company Profiles. The Summary encapsulates several key conclusions and includes a table of market findings. The Overview provides deep background information on the most important issues of the day, including the global supply chain crisis, QbD, and legislative prospects. The Technology section examines excipients by chemical compounds, functional uses, and delivery systems, and as finished products. The Industry Structure section discusses the market environment, strategies, influences, market shares, international aspects, and other related factors. The Company Profiles segment provides summaries of more than 120 companies that supply excipients or are relevant to the industry.

Chapters from this report can be purchased separately. Please contact us to find out more about this offer.

Speak to an Advisor

Call us on
+44 (0) 203 086 8600

Select License Type

Electronic License

Electronic License

An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.

Site License

Site License

An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.

Corporate License

Corporate License

An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£3,588.64

Change Currency

GBP EURO USD

Visitor Comments

All posts are pre-moderated and must obey the house rules.

Change Currency

GBP
USD

Healthcare and Medical Company Profiles

Find latest Healthcare and Medical Company Profiles with up to date financial, strategic, operational, SWOT analysis and product information for the leading healthcare and medical companies.

Competitor Tracking

Do you need to track your competitors and customers on a continuous basis? We have the expertise to provide you with a cost-effective, fully customised competitor tracking portal, which collates data on your competitors on a continuous basis. Contact us for a free consultation and demonstration.

Become an Affiliate

Do you manage an industry specific website or blog? Are you looking to monetise your web traffic further? Are you a B2B website?

Why not offer your visitors industry specific strategic market reports and company profiles? Our Affiliate Program enables you to provide quality content on your website and to earn money from passing on visitors to our website.

Custom Research

Cannot find what you need? We can tailor a report for you. Complete the Custom Research Form and we will provide a quote.

Accessibility
Close

Contrast settings

Text size settings